摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-diisopropylimidazolidineimine | 1220516-31-3

中文名称
——
中文别名
——
英文名称
1,3-diisopropylimidazolidineimine
英文别名
1,3-Di(propan-2-yl)imidazolidin-2-imine
1,3-diisopropylimidazolidineimine化学式
CAS
1220516-31-3
化学式
C9H19N3
mdl
——
分子量
169.27
InChiKey
MGUZDSKOWAVYFP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    30.3
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    1,3-diisopropylimidazolidineimine五氯化磷 作用下, 以 甲苯 为溶剂, 以67%的产率得到tetrakis(1,3-diisopropylimidazolidineimino)phosphonium chloride
    参考文献:
    名称:
    POLYALKYLENE GLYCOL PRODUCING CATALYST, AND METHOD FOR PRODUCING POLYALKYLENE GLYCOL USING SAME
    摘要:
    提供一种催化剂,由磷氮阳离子盐和活性氢化合物阴离子组成,易于合成,完全不含金属成分,且不会在产物上留下任何气味;一种其生产方法;以及通过该催化剂经济高效地生产聚烷氧化物的方法。使用磷氮阳离子盐和活性氢化合物阴离子组成的盐,其化学式如下(2):[在上述化学式(2)中,独立的R1和R2是C1-10烷基,未取代或取代的C6-10苯基,或未取代或取代的C6-10苯基烷基,但要求R1和R2,或R2的,可以连接成环形结构,n是1到8的实数,Yn-是通过从活性氢化合物Y中去除n个质子获得的活性氢化合物的阴离子]作为聚烷氧化物生产的催化剂。
    公开号:
    US20110178338A1
点击查看最新优质反应信息

文献信息

  • NOVEL GUANIDINE DERIVATIVES AND THEIR MEDICAL USE
    申请人:Sorensen Ulrik Svane
    公开号:US20090099208A1
    公开(公告)日:2009-04-16
    This invention relates to novel guanidine derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
    本发明涉及一种新型基衍生物,可用作小电导激活通道(SK通道)的调节剂。在其他方面,本发明涉及使用这些化合物的方法进行治疗,以及包括本发明化合物的制药组合物。
  • Rigid non-cyclopentadienyl group 4 transition metal and rare earth metal catalysts for olefin polymerization
    申请人:McMaster University
    公开号:US11214636B2
    公开(公告)日:2022-01-04
    The present application provides a catalyst component for alkene polymerization. The catalyst component contains: (a) a group 4 transition metal or rare earth metal, (b) a rigid non-cyclopentadienyl ligand with a tricyclic backbone composed of three ortho-fused 6-membered rings in a linear arrangement (as is the case in xanthene), with or without additional fused rings; the tricyclic backbone contains at least one donor atom within the central ring (as is the case for xanthene, oxanthrene, or acridan); furthermore, donor atoms/groups or aryl rings are attached directly (i.e. via the donor atom in the case of donor groups) to both of the bondable carbon atoms adjacent to at least one of the donor atoms within the central ring (e.g. xanthene with two donor groups, or two aryl rings, or one donor group and one aryl ring adjacent to oxygen), and (c) two or more activatable ligands, such as chloro, alkyl, aryl, allyl or hydride ligands, attached to the central metal if the complex is neutral or anionic, or one or more activatable ligand if the complex is monocationic or dicationic. The rigid non-cyclopentadienyl ligand has a charge of 0, 1- or 2- (considering all donor atoms of the ligand to have an octet of valence electrons). The catalyst component is optionally combined with an activator, typically for the purpose of generating a highly active monocationic or dicationic polymerization catalyst, and the catalyst and/or catalyst components may be in solution, precipitated from solution, or optionally carried on a support.
    本申请提供了一种用于烯烃聚合的催化剂组分。催化剂组分包含(a) 第 4 族过渡属或稀土属,(b) 具有三环骨架的刚性非环戊二烯配体三环骨架由三个呈线性排列的正交融合 6 元环组成(如呫吨),可有或无附加的融合环;三环骨架的中心环内至少含有一个供体原子(如氧杂蒽氧杂蒽吖啶);此外,供体原子/基团或芳基环是直接连接的(即:......)。e.此外,供体原子/基团或芳基环直接(即在供体基团的情况下通过供体原子)连接到与中心环内至少一个供体原子相邻的两个可键合碳原子上(如(c) 两个或多个可活化配体,如、烷基、芳基、烯丙基或氢化物配体,如果络合物为中性或阴离子络合物,则连接到中心属上;如果络合物为一价或二价络合物,则连接到一个或多个可活化配体上。刚性非环戊二烯配体的电荷量为 0、1- 或 2-(考虑到配体的所有供体原子都具有八价电子)。催化剂组分可选择性地与活化剂结合,通常是为了生成高活性的一元或二元聚合催化剂,催化剂和/或催化剂组分可以是溶液、从溶液中析出或可选择性地载于载体上。
  • JP6040747
    申请人:——
    公开号:——
    公开(公告)日:——
  • RIGID NON-CYCLOPENTADIENYL GROUP 4 TRANSITION METAL AND RARE EARTH METAL CATALYSTS FOR OLEFIN POLYMERIZATION
    申请人:McMaster University
    公开号:US20200308322A1
    公开(公告)日:2020-10-01
    The present application provides a catalyst component for alkene polymerization. The catalyst component contains: (a) a group 4 transition metal or rare earth metal, (b) a rigid non-cyclopentadienyl ligand with a tricyclic backbone composed of three ortho-fused 6-membered rings in a linear arrangement (as is the case in xanthene), with or without additional fused rings; the tricyclic backbone contains at least one donor atom within the central ring (as is the case for xanthene, oxanthrene, or acridan); furthermore, donor atoms/groups or aryl rings are attached directly (i.e. via the donor atom in the case of donor groups) to both of the bondable carbon atoms adjacent to at least one of the donor atoms within the central ring (e.g. xanthene with two donor groups, or two aryl rings, or one donor group and one aryl ring adjacent to oxygen), and (c) two or more activatable ligands, such as chloro, alkyl, aryl, allyl or hydride ligands, attached to the central metal if the complex is neutral or anionic, or one or more activatable ligand if the complex is monocationic or dicationic. The rigid non-cyclopentadienyl ligand has a charge of 0, 1- or 2- (considering all donor atoms of the ligand to have an octet of valence electrons). The catalyst component is optionally combined with an activator, typically for the purpose of generating a highly active monocationic or dicationic polymerization catalyst, and the catalyst and/or catalyst components may be in solution, precipitated from solution, or optionally carried on a support.
  • US8048877B2
    申请人:——
    公开号:US8048877B2
    公开(公告)日:2011-11-01
查看更多

同类化合物

辛基羟乙基咪唑啉 辛基羟乙基咪唑啉 苯丙酸,3,4-二羟基-a-羰基- 肉豆蔻基羟乙基咪唑啉 硬脂酸,氨基乙基乙醇胺酰胺-咪唑啉,羧甲基化钠盐 甲基-(1-甲基-吡咯烷-2-亚基)-胺 甲基(5-甲基-1,2-恶唑-3-基)氨基甲酸酯 油基胺乙基咪唑啉 油基羟乙基咪唑啉 氯代醋酸钠与4,5-二氢-十一烷基-1H-咪唑-1-乙醇和氢氧化钠的反应产物 氯二甲基(1-甲基-1-丙烯基)硅烷 氯-乙酸反应产物与2-庚基-4,5-二氢-1H-咪唑-1-乙醇和氢氧化钠 月桂基羟乙基咪唑啉 恶唑-4-基氨基甲酸叔丁酯 异硬脂基羟乙基咪唑啉 异噁隆 异丙基亚氨基吡咯烷 噻唑-2,4-二胺 噁唑-4-胺 叔-丁基2-氨基-6,7-二氢吡唑并[1,5-A]吡嗪-5(4H)-甲酸基酯 十七碳-2-烯基-4,5-二氢-1H-咪唑-1-乙醇盐酸盐 偶氮引发剂VA-064 依凡达明 二氨基吡唑 乙基3-(乙基氨基)-5-甲基-1,2-恶唑-4-羧酸酯 alpha-(氯甲基)-2-异丙基-5-硝基-2H-咪唑-2-乙醇 alpha,4,4-三甲基-2-十一烷基-2-咪唑啉-1-乙醇 Z-2-(8-十七烯基)-4,5-二氢-1H-咪唑-1-乙醇 N-甲基异噻唑-3-胺盐酸 N-甲基-N-(5-甲基-3-异恶唑基)-乙酰胺 N-甲基-3-氨基吡唑 N-甲基-2-吡咯烷酮肟 N-甲基-1,2-噻唑-3-胺1,1-二氧化物 N-环己基-1,2-噻唑-3-胺1,1-二氧化物 N-叔-丁基-5-甲基-2H-吡唑-3-胺 N-乙基-N-(5-甲基-3-异恶唑基)-乙酰胺 N-乙基-1,2-噻唑-3-胺1,1-二氧化物 N-乙基-1,2,5-恶二唑-3,4-二胺 N-{(E)-[(4-氨基-1,2,5-恶二唑-3-基)氨基]亚甲基}乙酰胺 N-[2-[2-[(E)-十七碳-8-烯基]-4,5-二氢咪唑-1-基]乙基]乙烷-1,2-二胺 N-[2-[2-(13-二十一碳烯-1-基)-4,5-二氢-1H-咪唑-1-基]乙基]乙二胺 N-[2-(4,5-二氢-2-十九烷基-1H-咪唑-1-基)乙基]乙二胺 N-[2-(4,5-二氢-2-十一烷基-1H-咪唑-1-基)乙基]乙二胺 N-[(2Z)-哌嗪-2-亚基]-2,2,2-三氟乙酰肼 N-[(2-甲基苯基)氨基甲硫杂酰]-2-(4-羰基-2-苯基喹唑啉-3(4H)-基)-3-苯基丙酰胺 N-BOC-4-氨基噻唑 N-3-异恶唑氨基甲酸叔丁酯 N-(噻二唑-4-基)氨基甲酸乙酯 N-(5-叔丁基-1H-吡唑-3-基)氨基甲酸甲酯 N-(4,5-二甲基-3-异噁唑)氨基甲酸1,1-二甲基乙酯